Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

GSK sells another chunk of South Africa’s Aspen

Paid $418m for an 18% share in Aspen in 2009

Webinar on-demand: The e-detailing wow factor in 2015

E-detailing and closed loop marketing is too often seen as a technical issue rather than a creative one. Yet to get the most from the technology you need to have...

Anthill Agency

- PMLiVE

Maetrics promotes Steve Cottrell to president

Was previously VP of business development

- PMLiVE

Takeda’s Entyvio recommended by NICE for bowel disease

But must supply the drug at a discounted rate to the NHS

Use of biomarkers in marketing

Mark Assenti talks about utilisation of biomarkers in marketing is a trend that we have seen growing in 2014 and expect to hear even more about into 2015.

Blue Latitude Health

- PMLiVE

AstraZeneca bullish on diabetes franchise fortunes

Other big pharma firms face a difficult 2015, but AZ is confident it won't

- PMLiVE

Keytruda is UK’s first early-access medicine

Merck’s melanoma therapy accepted under the UK’s EAMS

- PMLiVE

Endo tries to ride out Valeant with $15.7bn bid for Salix

Around $1.2bn more than rival bid

UK flag

Type 1 diabetes vaccine possible ‘within a generation’

Follows the injection of a new funding stream for its research

- PMLiVE

Recipharm promotes Thomas Beck to VP quality management

He joined the organisation in 2010

- PMLiVE

NICE set to back Novartis’ Xolair for skin condition CSU

Issues final draft guidance on the treatment's use as an add-on for chronic spontaneous urticaria

- PMLiVE

Adaptimmune appoints Lawrence Alleva to its board

The former PwC partner will also chair its boardaudit committee

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links